Sloan Kettering Institute for Cancer Research Researchers Synthesize Erythropoietin Ushering In New Era Of Biotech Drugs
12/13/2013 6:58:46 AM
A team of researchers working at the Sloan Kettering Institute for Cancer Research has succeeded in building a glycoprotein from scratch. It marks an enormous step forward, the team reports in their paper published in the journal Science, in the creation of biotech drugs without the need for living cells. Modern drugs tend to fall into two main categories, those that are made of small molecules and come about due to chemical reactions, and those that are created using living cells.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by